Viewing Study NCT01436968


Ignite Creation Date: 2025-12-24 @ 5:44 PM
Ignite Modification Date: 2025-12-29 @ 1:51 AM
Study NCT ID: NCT01436968
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-07-30
First Post: 2011-09-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Sponsor: Candel Therapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module